Use of Hyaluronic Acid as a Therapeutic Strategy for Bone Repair in Human

Sponsor
Federal University of Minas Gerais (Other)
Overall Status
Completed
CT.gov ID
NCT02709525
Collaborator
(none)
16
2
44

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the effects of hyaluronic acid (HA) on bone healing in human dental sockets.

Condition or Disease Intervention/Treatment Phase
  • Drug: hyaluronic acid
  • Other: Placebo
Phase 1/Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Use of Hyaluronic Acid as a Therapeutic Strategy for Bone Repair in Human: a Split-mouth Randomized Triple-blind Clinical Trial
Study Start Date :
Jul 1, 2012
Actual Primary Completion Date :
Jul 1, 2015
Actual Study Completion Date :
Mar 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: hyaluronic acid

Immediately after the extractions, one socket was randomly filled with 1% hyaluronic acid gel.

Drug: hyaluronic acid
Other Names:
  • Hyaluronan
  • Sodium hyaluronate
  • Placebo Comparator: Blood clot

    Immediately after the extractions, the other side socket was naturally filled with blood clot.

    Other: Placebo

    Outcome Measures

    Primary Outcome Measures

    1. Percentage of bone formation [30 days after extraction and treatment application]

      During the postoperative interval of 30 days, the patients underwent cone beam computed tomography (CBCT). Five central transverse scan images were captured from each socket. Using the KS300 software, the gray intensity was measured in each image and the results were expressed as mean percentage of bone formation

    2. Fractal dimension [30 days after extraction and treatment application]

      During the postoperative interval of 30 days, the patients underwent cone beam computed tomography (CBCT). Five central transverse scan images were captured from each socket. The pattern of the alveolar trabecular bone was also evaluated through the fractal dimension in each image.

    3. Dimensional Alveolar changes [30 to 90 days after extraction and treatment application]

      To determine whether treatment could prevent loss of buccolingual thickness, was compared bone loss of 90 to 30 days between the treated and control groups.

    4. Percentage of bone formation [90 days after extraction and treatment application]

      During the postoperative interval of 90 days, the patients underwent cone beam computed tomography (CBCT). Five central transverse scan images were captured from each socket. Using the KS300 software, the gray intensity was measured in each image and the results were expressed as mean percentage of bone formation

    5. Fractal dimension [90 days after extraction and treatment application]

      During the postoperative interval of 90 days, the patients underwent cone beam computed tomography (CBCT). Five central transverse scan images were captured from each socket. The pattern of the alveolar trabecular bone was also evaluated through the fractal dimension in each image.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    14 Years to 40 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Orthodontic need for bilateral extraction of lower first premolars
    Exclusion Criteria:
    • Alcoholism, smoking, drug use and abuse of drugs; Systemic diseases: uncontrolled diabetes, blood dyscrasias, kidney or heart failure and osteoporosis; clinical or radiographic signs of pathological processes in the bone;

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Federal University of Minas Gerais

    Investigators

    • Study Director: Anderson Ferreira, Professor, Instituto de Ciências Biológicas - Universidade Federal de Minas Gerais

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Carlos Eduardo Pinto de Alcântara, MSc,PhD Student, Professor, Federal University of Minas Gerais
    ClinicalTrials.gov Identifier:
    NCT02709525
    Other Study ID Numbers:
    • CAAE: 0328.0.203.000-10
    First Posted:
    Mar 16, 2016
    Last Update Posted:
    Mar 16, 2016
    Last Verified:
    Mar 1, 2016
    Keywords provided by Carlos Eduardo Pinto de Alcântara, MSc,PhD Student, Professor, Federal University of Minas Gerais
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 16, 2016